Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody that displays anti-proliferative, apoptotic, and antibody-dependent cytotoxic effects in vitro and inhibits tumor growth in mice harboring human lymphomas, and is indicated for use in non-Hodgkins lymphoma (NHL).
Purity:
95.00%
CAS Number:
[728917-18-8]
Target:
Immunology/Inflammation related|||Integrin
* VAT and and shipping costs not included. Errors and price changes excepted